June 22, 2017
A Pennsylvania federal judge agreed Thursday to allow the Third Circuit to weigh in on whether he should have granted a motion from Pfizer Inc. to throw out a whistleblower suit accusing the company of pushing illegal off-label use of its antifungal medication Vfend.
April 12, 2017
A Pennsylvania federal judge on Wednesday denied Pfizer Inc.'s bid to dismiss a False Claims Act suit alleging the company pushed illegal off-label use of its anti-fungal medication Vfend, ruling the suit was not filed too late.
March 02, 2016
A Pennsylvania federal judge on Monday trimmed a False Claims Act suit against Pfizer Inc., but left room for the whistleblowers to refile and pursue other claims alleging illegal off-label marketing and kickback practices relating to the drugmaker's anti-fungal medication Vfend.
November 29, 2011
A federal court on Tuesday unsealed two ex-Pfizer Inc. employees' qui tam suit alleging the drugmaker marketed anti-fungal medication Vfend for off-label use that put patients at risk and caused the submission of millions of dollars in claims to government programs in violation of the False Claims Act.